<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24913" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Toxic Megacolon</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Skomorochow</surname>
            <given-names>Ewelina</given-names>
          </name>
          <aff>St. Lucie Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pico</surname>
            <given-names>Jose</given-names>
          </name>
          <aff>Saint Lucie Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ewelina Skomorochow declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jose Pico declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24913.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Toxic megacolon is a rare, but potentially deadly complication of colonic inflammation. It is defined as a nonobstructive dilation of the colon, which can be total or segmental and is usually associated with systemic toxicity. This activity outlines the evaluation, diagnosis, treatment, and management of toxic megacolon. It also includes essential information about patients at risk for toxic megacolon and when surgical intervention might be necessary. Furthermore, it discusses the role of the interprofessional team in managing and caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of toxic megacolon.</p></list-item><list-item><p>Review the evaluation process for toxic megacolon.</p></list-item><list-item><p>Outline the treatment and management options available for toxic megacolon.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance toxic megacolon and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24913&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24913">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24913.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Toxic megacolon is a rare but potentially deadly complication of colonic inflammation. Its definition is a nonobstructive dilation of the colon, which can be total or segmental and is usually associated with systemic toxicity.<xref ref-type="bibr" rid="article-24913.r1">[1]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref> It is most commonly associated with inflammatory bowel disease, especially ulcerative colitis, yet any condition that leads to inflammation of the colon can potentially cause toxic megacolon.<xref ref-type="bibr" rid="article-24913.r3">[3]</xref></p>
      </sec>
      <sec id="article-24913.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Toxic megacolon can be a potential complication of any disease-causing infectious colitis. The common causes include&#x000a0;<xref ref-type="bibr" rid="article-24913.r2">[2]</xref><xref ref-type="bibr" rid="article-24913.r4">[4]</xref>:</p>
        <p>
<bold>Inflammatory Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0; Ulcerative colitis</p>
          </list-item>
          <list-item>
            <p>&#x000a0; Crohn disease</p>
          </list-item>
        </list>
        <p>&#x000a0;<bold>Infectious Causes</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0; <italic toggle="yes">Clostridium difficile</italic></p>
          </list-item>
          <list-item>
            <p>&#x000a0; Salmonella</p>
          </list-item>
          <list-item>
            <p>&#x000a0; Shigella</p>
          </list-item>
          <list-item>
            <p>&#x000a0; Campylobacter colitis</p>
          </list-item>
          <list-item>
            <p>&#x000a0; Enterohemorrhagic or enteroaggregative <italic toggle="yes">Escherichia coli</italic> O157 (can lead to hemolytic-uremic syndrome)</p>
          </list-item>
          <list-item>
            <p>&#x000a0; <italic toggle="yes">Cytomegalovirus</italic></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0; <italic toggle="yes">Entamoeba</italic></p>
          </list-item>
        </list>
        <p><bold>Ischemia</bold>&#x000a0;</p>
        <p>Of note, <italic toggle="yes">Cytomegalovirus</italic> is the leading cause of toxic megacolon in HIV and AIDS patients, especially in those who have disseminated cytomegalovirus.<xref ref-type="bibr" rid="article-24913.r4">[4]</xref> Whereas <italic toggle="yes">Entamoeba</italic> is the least common cause&#x000a0;<xref ref-type="bibr" rid="article-24913.r2">[2]</xref>.&#x000a0;</p>
        <p>Factors that can precipitate toxic megacolon include, but are not limited to&#x000a0;<xref ref-type="bibr" rid="article-24913.r5">[5]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypokalemia</p>
          </list-item>
          <list-item>
            <p>Medications (antimotility agents, opiates, anticholinergics, antidepressants)</p>
          </list-item>
          <list-item>
            <p>Barium enema</p>
          </list-item>
          <list-item>
            <p>Colonoscopy &#x00026; bowel preparations</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24913.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of toxic megacolon in the general population is unknown. Toxic megacolon can occur in males and females of all ages. Nevertheless, people at most risk are those with inflammatory bowel disease, especially in the early phase of the disease.<xref ref-type="bibr" rid="article-24913.r1">[1]</xref> Involvement during early disease can be seen more often in Crohn disease before fibrotic colon damage. Once severe fibrosis occurs, the colon cannot dilate.<xref ref-type="bibr" rid="article-24913.r6">[6]</xref><xref ref-type="bibr" rid="article-24913.r5">[5]</xref> However, the incidence in people with inflammatory bowel disease has been a topic of study, and the results are somewhat conflicting; some studies show higher incidence in patients with ulcerative colitis versus Crohn disease (8 to 10% vs. 2.3%), whereas others show higher incidence in Crohn disease (1 to 2.5% vs. 4.4 to 6.3%).<xref ref-type="bibr" rid="article-24913.r3">[3]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref><xref ref-type="bibr" rid="article-24913.r6">[6]</xref></p>
        <p><italic toggle="yes">Clostridium difficile</italic> infection can be asymptomatic or can lead to severe disease with toxic megacolon.<xref ref-type="bibr" rid="article-24913.r7">[7]</xref><xref ref-type="bibr" rid="article-24913.r8">[8]</xref><xref ref-type="bibr" rid="article-24913.r9">[9]</xref> Over the past few years, the number of <italic toggle="yes">C. difficile</italic> colitis related toxic megacolon cases has been increasing. Before 1990 there was an increase from 0.4% to 3%, and after 1990 to 4.3% in proportion to its prevalence.<xref ref-type="bibr" rid="article-24913.r3">[3]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref> Asymptomatic <italic toggle="yes">C. difficile</italic> infection occurs in about 20% of hospitalized patients, and symptomatic <italic toggle="yes">C. difficile</italic> infection presents in 1% of hospitalized patients.<xref ref-type="bibr" rid="article-24913.r5">[5]</xref><xref ref-type="bibr" rid="article-24913.r10">[10]</xref><xref ref-type="bibr" rid="article-24913.r11">[11]</xref><xref ref-type="bibr" rid="article-24913.r12">[12]</xref></p>
      </sec>
      <sec id="article-24913.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of toxic megacolon is not entirely known. Nevertheless, one of the possible mechanisms proposed suggests that mucosal inflammation initiates the process. It releases inflammatory mediators, bacterial products and increases the production of inducible nitric oxide synthase, which in turn increases nitric oxide, and thus causes dilation of the colon. A study showed that patients with&#x000a0;toxic megacolon have significantly high levels of inducible nitric oxide synthase in the muscularis propria, which could support this proposed mechanism.<xref ref-type="bibr" rid="article-24913.r13">[13]</xref> Additionally, toxic megacolon leads to inflammation of the smooth muscle of the colon, which causes its paralysis and eventually dilation.<xref ref-type="bibr" rid="article-24913.r14">[14]</xref></p>
      </sec>
      <sec id="article-24913.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Dilation of the colon, thinning of the colonic wall, and deep ulcers are gross features that toxic megacolon shares with ulcerative colitis and Crohn&#x02019;s disease. However, the hallmark of toxic megacolon is acute transmural inflammation of the colon with necrosis and granulation tissue, filled with inflammatory cells, such as neutrophils and lymphocytes. The muscle fibers are usually shortened and rounded with collections of eosinophilic cytoplasm.</p>
        <p>A key feature that distinguishes toxic megacolon from the neuropathic process is the presence of submucosal and myenteric plexi within the colon.<xref ref-type="bibr" rid="article-24913.r5">[5]</xref></p>
      </sec>
      <sec id="article-24913.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough history of the patient is critical. Knowing the patient&#x02019;s medical history ahead of time, HIV/AIDS status, medications, or exposures can help point physicians towards the right diagnosis. It is imperative to review the patient's medication as some (like steroids) can mask the full picture of toxic megacolon, and others can aggravate it (anticholinergics or opioids, for example).<xref ref-type="bibr" rid="article-24913.r5">[5]</xref> Patients presenting with diarrhea and abdominal pain or distension should increase the suspicion index of toxic megacolon.</p>
        <p>Patients with a diagnosis of toxic megacolon will look toxic. Those patients are critically ill and usually present with abdominal pain and distention, nausea, vomiting, diarrhea (may or may not be bloody), and altered sensorium. On physical exam, abdominal tenderness and decreased bowel sounds are usually present.<xref ref-type="bibr" rid="article-24913.r5">[5]</xref><xref ref-type="bibr" rid="article-24913.r11">[11]</xref> In a study that focused on patients with C. difficile infection and toxic megacolon, the three most commonly seen complaints were diarrhea, malaise, and abdominal pain/distension.<xref ref-type="bibr" rid="article-24913.r11">[11]</xref></p>
        <p>Comorbidities are frequently seen in those patients, as well. Clinicians can expect to find fluid and electrolyte imbalance, hypotension, anemia, weight loss, uncomplicated diabetes, and renal failure.<xref ref-type="bibr" rid="article-24913.r15">[15]</xref></p>
        <p>Peritonitis symptoms (fever, abdominal pain, tenderness, altered mental status, hypotension) could indicate bowel perforation. Patients who have received steroids&#x000a0;may not show this picture as steroids can mask some of those symptoms. Nevertheless, if the patient continues to have a fever for 2 or 3 days while being treated with steroids, the clinician should consider the possibility of a perforated bowel.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
      </sec>
      <sec id="article-24913.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnostic basis is the patient&#x02019;s systemic symptoms and greater than 6 cm dilation of the colon seen on radiographic images.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref> Below are the most commonly used diagnostic criteria for toxic megacolon (by Jalan et al.)&#x000a0;<xref ref-type="bibr" rid="article-24913.r1">[1]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Radiographic evidence of the dilation of the colon greater than 6 cm&#x000a0;<bold>AND</bold>:</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>At least <bold>three</bold> of the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Fever over 38 degrees C</p>
              </list-item>
              <list-item>
                <p>Heart rate greater than 120 beats/min</p>
              </list-item>
              <list-item>
                <p>Neutrophilic leukocytosis exceeding 10500/micro/L</p>
              </list-item>
              <list-item>
                <p>Anemia</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>At least <bold>one</bold> of the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Dehydration&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Altered sensorium</p>
              </list-item>
              <list-item>
                <p>Electrolyte disturbances</p>
              </list-item>
              <list-item>
                <p>Hypotension</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>
<bold>Vital Signs and Laboratory</bold>
</p>
        <p>Vital signs and laboratory results will show fever, tachycardia, anemia, and leukocytosis with a left shift. Increase inflammatory markers, such as erythrocyte sedimentation rate, and C-reactive protein, are also commonly seen.&#x000a0;Patients who present with severe diarrhea and volume loss can present with hypokalemia and hypoalbuminemia; this generally indicates poor prognosis.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
        <p>
<bold>Radiography</bold>
</p>
        <p>Plain abdominal imaging is still the most frequently utilized modality; however, computed tomography (CT) is seeing increasing use, especially because it can provide more reliable information about the severity of the disease.&#x000a0;CT is commonly used to assess possible complications of toxic megacolon,&#x000a0;which include abscess, perforation, or ascending pylephlebitis.&#x000a0;</p>
        <p>Key features visible on CT include colonic wall thickening, pericolic stranding, bands of high and low intensity stretching over thickened submucosal folds (accordion sign), and multilayers appearance due to alternating densities of edematous submucosa and hyperemic mucosa (target sign).&#x000a0;&#x000a0;</p>
        <p>An abdominal ultrasound is also an option, but it provides nonspecific findings that might not always help with diagnosis.<xref ref-type="bibr" rid="article-24913.r16">[16]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
        <p>
<bold>Colonoscopy</bold>
</p>
        <p>Colonoscopy is not necessary for diagnosis. Therefore,&#x000a0;colonoscopy is discouraged due to the high risk of perforation.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
      </sec>
      <sec id="article-24913.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment focuses on medical management and supportive care to decompress the colon to avoid perforation. The treatment of the underlying cause, correction of any electrolyte disturbances (ex. hypokalemia), symptom management, and&#x000a0;prevention of further complications&#x000a0;are also important components of a good treatment plan.<xref ref-type="bibr" rid="article-24913.r15">[15]</xref></p>
        <p>
<bold>Medical Management</bold>
</p>
        <p>Initial treatment involves supportive therapy and medical management. This approach is usually successful in about half of the patients. Patients should obtain admission to the intensive care unit in case of unexpected deterioration. Initially, checking complete blood count, abdominal films, and electrolytes should take place every 12 hours. Once patients improve, images and labs can scale back to once daily. All the medications which can aggravate the megacolon, such as opioids, anticholinergics, etc., should be stopped. Patients should be started on IV fluids to provide adequate hydration.<xref ref-type="bibr" rid="article-24913.r17">[17]</xref> Due to the high risk of perforation, patients are frequently placed on antibiotics, especially if an infectious cause is suspected. The most commonly used antibiotics are metronidazole or vancomycin.<xref ref-type="bibr" rid="article-24913.r18">[18]</xref><xref ref-type="bibr" rid="article-24913.r19">[19]</xref> If cytomegalovirus is the suspected cause, then gancyclovir should be&#x000a0;given.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref> Antibiotics of choice for <italic toggle="yes">C. difficile</italic> are&#x000a0;oral vancomycin or oral fidaxomicin. If those are not available, oral metronidazole is an alternative.<xref ref-type="bibr" rid="article-24913.r7">[7]</xref></p>
        <p>Patients with ulcerative colitis should also be given steroids as soon as possible. Generally, the recommendation is hydrocortisone 100 mg over 6 hours (400 mg daily) or methylprednisone 60 mg daily for 5 days. Higher doses did not show significant benefits.<xref ref-type="bibr" rid="article-24913.r18">[18]</xref> Several studies have shown the benefits of using cyclosporine and infliximab in patients with ulcerative colitis. However, those studies did not use patients who presented with&#x000a0;toxic megacolon; thus, they are generally not recommended as part of the treatment.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
        <p>Lastly, patients must be on bowel rest. A nasogastric tube can be inserted to help decompress the stomach, but it will not decompress the colon. As the patient continues to improve, they can gradually start eating to promote gut healing.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
        <p>
<bold>Surgical Management</bold>
</p>
        <p>A surgeon should be involved in the patient's care from day 1, in case intervention might be necessary. The current surgical treatment of choice in acute toxic megacolon is subtotal colectomy with ileostomy and either a Hartmann pouch, sigmoidostomy, or rectostomy. Previously there were two additional surgical methods used: total proctocolectomy and the Turnbull method. Turnbull's method was essentially a colon decompression technique that served to prepare a patient for a colectomy. However, studies showed that this method was associated with increased bleeding and high mortality (71%) versus those with subtotal colectomy with ileostomy (8%). Studies conducted with patients treated with total proctocolectomy showed a mortality of 21%.<xref ref-type="bibr" rid="article-24913.r3">[3]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
        <p>The exact time of surgery in toxic megacolon patients is still unclear. If there is perforation, bleeding, or clinical deterioration of a patient, surgical intervention is unavoidable. Nevertheless, some studies&#x000a0;conclude favorable outcomes in patients where surgical intervention is done soon after making the diagnosis of toxic megacolon, whereas other studies show an increase in mortality, especially in patients older than 65.<xref ref-type="bibr" rid="article-24913.r20">[20]</xref> Therefore, surgeons and hospitalists need to work together and assess the patient on a daily basis.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref> This collaboration is essential because colon perforation correlates with a worse prognosis, and it increases mortality by 3 to 5 times.<xref ref-type="bibr" rid="article-24913.r3">[3]</xref><xref ref-type="bibr" rid="article-24913.r15">[15]</xref></p>
      </sec>
      <sec id="article-24913.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis includes <xref ref-type="bibr" rid="article-24913.r21">[21]</xref><xref ref-type="bibr" rid="article-24913.r2">[2]</xref><xref ref-type="bibr" rid="article-24913.r22">[22]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hirschsprung disease</p>
          </list-item>
          <list-item>
            <p>Acquired megacolon</p>
          </list-item>
          <list-item>
            <p>Colonic pseudo-obstruction (Ogilvie syndrome)</p>
          </list-item>
          <list-item>
            <p>Diffuse gastrointestinal dysmotility</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24913.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>For patients with inflammatory bowel disease, the mortality rates are around 0 to 2%; this is attributable to multiple factors, such as early intervention and better treatment.<xref ref-type="bibr" rid="article-24913.r23">[23]</xref> Colon perforation correlates with a worse prognosis, and it increases mortality by 3 to 5 times.<xref ref-type="bibr" rid="article-24913.r3">[3]</xref><xref ref-type="bibr" rid="article-24913.r15">[15]</xref> However, according to one study, if the patient has surgery earlier, it can decrease the mortality from 22% to 1.2%, whereas other studies show an increase in mortality, especially in patients older than 65.<xref ref-type="bibr" rid="article-24913.r24">[24]</xref><xref ref-type="bibr" rid="article-24913.r20">[20]</xref></p>
      </sec>
      <sec id="article-24913.s12" sec-type="Complications">
        <title>Complications</title>
        <p>If toxic megacolon does not receive proper treatment, it has a risk of rupture. Bowel perforation, peritonitis, abscess, and abdominal compartment syndrome are severe complications that warrant immediate surgical intervention.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref></p>
      </sec>
      <sec id="article-24913.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although toxic megacolon is a relatively rare disease, patients should receive education about this condition, especially those with inflammatory bowel disease. Since those patients are at an increased risk of developing toxic megacolon, they should understand the precipitating factors as well as potential symptoms. Early diagnosis and treatment can increase the chances of survival.</p>
      </sec>
      <sec id="article-24913.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Toxic megacolon is a medical emergency that demands urgent attention. Failure to recognize the disorder is associated with high mortality and morbidity. Thus, optimal disorder management is best by an interprofessional team. Assistance from a radiologist is vital to make the diagnosis. These patients need ICU care with close monitoring. Nurses should be aware of the potential complications of the disorder and communicate with the surgeon if the patient has signs of peritonitis. Aggressive hydration, replacement of electrolytes, and antibiotics are essential. The pharmacist should check the patient's medication record to ensure that they are on no medications that cause ileus and is on appropriate antibiotics. While most patients do recover with medical therapy, some may require surgery.</p>
        <p>The surgical group should be involved early in the process in case initial therapy fails and surgery is unavoidable. High risk of colon perforation and abdominal compartment syndrome are situations where surgery is necessary to avoid further complications.<xref ref-type="bibr" rid="article-24913.r2">[2]</xref> Medical and surgical teams should evaluate patients daily and determine if&#x000a0;they&#x000a0;would benefit more from surgery than medical management. Surgical and/or gastroenterology specialty-trained nursing staff can assist in the surgery, monitoring the patient (in surgical and non-surgical cases, respectively), and being aware of possible adverse drug effects. They can also check that treatment is trending positively and alert the treating clinician or surgeon of any relapse. Close communication between interprofessional team members is vital if one wants to improve outcomes. Level III</p>
        <p>Disclaimer: This research was supported (in whole or part) by HCA Healthcare and/or an HCA Healthcare affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities.</p>
      </sec>
      <sec id="article-24913.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24913&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24913">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/toxic-megacolon/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24913">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24913/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24913">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24913.s16">
        <fig id="article-24913.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Toxic megacolon Contributed by WikiUser:Hellerhoff; (CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0/deed.en) 
Image courtesy: https://commons.wikimedia.org/wiki/File:Toxisches_Megacolon_bei_Colitis_ulcerosa.jpg</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Toxisches_Megacolon_bei_Colitis_ulcerosa" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24913.s17">
        <fig id="article-24913.image.f2" position="float" orientation="portrait">
          <caption>
            <p>CT Toxic megacolon Image courtesy O.Chaigasame</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="toxic__megacolon__CT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24913.s18">
        <title>References</title>
        <ref id="article-24913.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jalan</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Sircus</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Card</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Falconer</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Bruce</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Crean</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>McManus</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Small</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>An experience of ulcerative colitis. I. Toxic dilation in 55 cases.</article-title>
            <source>Gastroenterology</source>
            <year>1969</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-82</page-range>
            <pub-id pub-id-type="pmid">5305933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Autenrieth</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Baumgart</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Toxic megacolon.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>584</fpage>
            <page-range>584-91</page-range>
            <pub-id pub-id-type="pmid">22009735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ausch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Madoff</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Gnant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Garcia-Aguilar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>H&#x000f6;lbling</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Herbst</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Buxhofer</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Holzer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rothenberger</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Schiessel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Aetiology and surgical management of toxic megacolon.</article-title>
            <source>Colorectal Dis</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-201</page-range>
            <pub-id pub-id-type="pmid">16466559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hommes</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Sterringa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van Deventer</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Tytgat</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Weel</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2004</year>
            <month>May</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-50</page-range>
            <pub-id pub-id-type="pmid">15290919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norland</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kirsner</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1969</year>
            <month>May</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-50</page-range>
            <pub-id pub-id-type="pmid">5769743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grieco</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Bordan</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Geiss</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Beil</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Toxic megacolon complicating Crohn's colitis.</article-title>
            <source>Ann Surg</source>
            <year>1980</year>
            <month>Jan</month>
            <volume>191</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">7352781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Gerding</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bakken</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Coffin</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Dubberke</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Garey</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shaklee Sammons</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sandora</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Wilcox</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).</article-title>
            <source>Clin Infect Dis</source>
            <year>2018</year>
            <month>Mar</month>
            <day>19</day>
            <volume>66</volume>
            <issue>7</issue>
            <fpage>e1</fpage>
            <page-range>e1-e48</page-range>
            <pub-id pub-id-type="pmid">29462280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagdasarian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Malani</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of Clostridium difficile in adults: a systematic review.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Jan</month>
            <day>27</day>
            <volume>313</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-408</page-range>
            <pub-id pub-id-type="pmid">25626036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>LaMont</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Clostridium difficile--more difficult than ever.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Oct</month>
            <day>30</day>
            <volume>359</volume>
            <issue>18</issue>
            <fpage>1932</fpage>
            <page-range>1932-40</page-range>
            <pub-id pub-id-type="pmid">18971494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hokama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ohira</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kishimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kinjo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Impending megacolon: small bowel distension as a predictor of toxic megacolon in ulcerative colitis.</article-title>
            <source>Intern Emerg Med</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>487</fpage>
            <page-range>487-8</page-range>
            <pub-id pub-id-type="pmid">22843318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trudel</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Desch&#x000ea;nes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mayrand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barkun</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Toxic megacolon complicating pseudomembranous enterocolitis.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>10</issue>
            <fpage>1033</fpage>
            <page-range>1033-8</page-range>
            <pub-id pub-id-type="pmid">7555415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carling</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Defining surgical therapy for pseudomembranous colitis with toxic megacolon.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>2008</year>
            <season>May-Jun</season>
            <volume>42</volume>
            <issue>5</issue>
            <fpage>476</fpage>
            <page-range>476-80</page-range>
            <pub-id pub-id-type="pmid">18277885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mourelle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casellas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guarner</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Salas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Riveros-Moreno</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moncada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malagelada</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon.</article-title>
            <source>Gastroenterology</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>109</volume>
            <issue>5</issue>
            <fpage>1497</fpage>
            <page-range>1497-502</page-range>
            <pub-id pub-id-type="pmid">7557131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tariq</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farooq</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wijesinghe</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Toxic colonoscopy--how investigating active inflammatory bowel disease can lead to the serious complication of toxic megacolon.</article-title>
            <source>BMJ Case Rep</source>
            <year>2015</year>
            <month>Jul</month>
            <day>22</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">26202312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doshi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Decter</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Doshi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States.</article-title>
            <source>Intern Emerg Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>881</fpage>
            <page-range>881-887</page-range>
            <pub-id pub-id-type="pmid">29948833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imbriaco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Balthazar</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Toxic megacolon: role of CT in evaluation and detection of complications.</article-title>
            <source>Clin Imaging</source>
            <year>2001</year>
            <season>Sep-Oct</season>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>349</fpage>
            <page-range>349-54</page-range>
            <pub-id pub-id-type="pmid">11682295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Present</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Wolfson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gelernt</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>1988</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>485</fpage>
            <page-range>485-90</page-range>
            <pub-id pub-id-type="pmid">3183326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Travis</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Stange</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>L&#x000e9;mann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oresland</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bemelman</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Chowers</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Colombel</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>D'Haens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marteau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kruis</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mortensen</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Penninckx</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gassull</surname>
                <given-names>M</given-names>
              </name>
              <collab>European Crohn's and Colitis Organisation (ECCO)</collab>
            </person-group>
            <article-title>European evidence-based Consensus on the management of ulcerative colitis: Current management.</article-title>
            <source>J Crohns Colitis</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-62</page-range>
            <pub-id pub-id-type="pmid">21172195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hung</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Rotavirus gastroenteritis complicated with toxic megacolon.</article-title>
            <source>Acta Paediatr</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>11</issue>
            <fpage>1850</fpage>
            <page-range>1850-2</page-range>
            <pub-id pub-id-type="pmid">19650837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Amico</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Angriman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ruffolo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Berto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vella</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Scarpa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Early surgery for the treatment of toxic megacolon.</article-title>
            <source>Digestion</source>
            <year>2005</year>
            <volume>72</volume>
            <issue>2-3</issue>
            <fpage>146</fpage>
            <page-range>146-9</page-range>
            <pub-id pub-id-type="pmid">16172551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanek</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Al-Salti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1986</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-10</page-range>
            <pub-id pub-id-type="pmid">3753674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Giorgio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarnelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corinaldesi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stanghellini</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction.</article-title>
            <source>Gut</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>53</volume>
            <issue>11</issue>
            <fpage>1549</fpage>
            <page-range>1549-52</page-range>
            <pub-id pub-id-type="pmid">15479666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danovitch</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Fulminant colitis and toxic megacolon.</article-title>
            <source>Gastroenterol Clin North Am</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-82</page-range>
            <pub-id pub-id-type="pmid">2493427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24913.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flatmark</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fretheim</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gjone</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Early colectomy in severe ulcerative colitis.</article-title>
            <source>Scand J Gastroenterol</source>
            <year>1975</year>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-31</page-range>
            <pub-id pub-id-type="pmid">1153936</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
